ArticleFrontiers in endocrinology2025
Comparison of different insulin resistance surrogates in predicting hyperuricemia in non-diabetic Yi residents in Yunnan Province.
Article in Frontiers in endocrinology, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Association between TyHGB and hyperuricemia and gout in patients with type-2 diabetes mellitus.BMC endocrine disorders · 2026Article
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
14 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background and purpose: Hyperuricemia (HUA) is one of the most common metabolic diseases in China, with an incidence of up to 36% across different ethnic groups. Insulin resistance (IR) plays a specific role in the occurrence and development of HUA, but relevant studies on the non-diabetic Yi residents in Yunnan are limited. Our study aimed to explore the triglyceride-glucose index (TyG), triglyceride-glucose and body mass index (TyG-BMI), triglyceride/high-density lipoprotein cholesterol ratio (TG/HDL-C), and the metabolic score for insulin resistance (METS-IR) among non-diabetic Yi residents in Yunnan Province, and identify the IR surrogates with high predictive ability for HUA. Materials and methods: From November 2018 to September 2023, our group finally included 765 Yi residents aged ≥18 years on the basis of the inclusion criteria. The participants were divided into the non-HUA and HUA groups. Logistic regression analysis was used to describe the association between four IR surrogates and HUA and calculate odds ratios (ORs), while the receiver operating characteristic curve was utilized to assess the prediction ability of these four IR surrogates. Results: Among the 765 non-diabetic Yi residents in Yunnan, 666 were in the non-HUA group, and 99 were in the HUA group. A history of smoking, alcohol consumption, hypertension, and hyperlipidemia, body mass index (BMI) ≥ 24 kg/m Conclusion: This study found that in non-diabetic Yi residents in six areas of Yunnan Province, the TyG, TyG-BMI, TG/HDL-C, and METS-IR were positively correlated with HUA. These four IR surrogates were good at predicting HUA.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.